SCHEMBL29046455

SCHEMBL29046455

CCCCCCCCC(CC=CCO)CCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
ALDH1A1 P00352 2/20 0.38
FFAR1 O14842 2/20 0.37
FFAR4 Q5NUL3 1/20 0.37
CYP2D6 P10635 2/20 0.36
SPHK1 Q9NYA1 2/20 0.36
GMNN O75496 1/20 0.36
POLB P06746 1/20 0.36
THPO P40225 1/20 0.36
MTOR P42345 1/20 0.36
BLM P54132 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
CETP P11597 1/20 0.36
HTT P42858 1/20 0.36
UBE2N P61088 1/20 0.36
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19511360 0.92 ALDH1A1 (0.45) LMNAALDH1A1CYP3A4TSHRFDPS
SCHEMBL28049401 0.82 FFAR1 (0.49) LMNAFFAR1FFAR4GMNNPOLB
SCHEMBL28049400 0.82 FFAR1 (0.45) LMNAFFAR1FFAR4GMNNPOLB
SCHEMBL28049412 0.82 FFAR1 (0.49) LMNAFFAR1FFAR4GMNNPOLB
SCHEMBL28049354 0.82 FFAR1 (0.49) LMNAFFAR1FFAR4GMNNPOLB
SCHEMBL28049424 0.82 FFAR1 (0.49) LMNAFFAR1FFAR4GMNNPOLB
SCHEMBL5594684 0.79 LMNA (0.41) LMNAALDH1A1FFAR1FFAR4SPHK1
SCHEMBL2052115 0.79 LMNA (0.50) LMNAALDH1A1FFAR1FFAR4HSD17B10
SCHEMBL8143856 0.78 FFAR1 (0.57) LMNAFFAR1FFAR4CYP2D6SPHK1
SCHEMBL6438441 0.78 FFAR1 (0.45) LMNAFFAR1FFAR4GMNNPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116601152-A Pyrrolopyridine-anilines for the treatment of cognitive dysfunction 恩福莱克逊治疗有限公司 2023-08-15 CN disclosed
CN-116549389-A Intranasal adrenergic formulations and methods of treating diseases 爱奇司治疗公司 2023-08-08 CN disclosed